The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.

China’s BeiGene, which is developing a portfolio of immuno-oncology drugs, has struck a deal with a Chinese development agency to build a biologics plant to…

Mylan and Biocon today won a court ruling that said they may sell their Herceptin biosimilar in India where it was first introduced three years ago.

India’s largest drugmakers want the U.S. to import their drugs to hold down healthcare costs. But questions on manufacturing quality are clouding their efforts.

India’s Wockhardt has received an FDA warning letter for a plant in the U.S., making an even half-dozen warning letters for seven Wockhardt plants, three of…

Novartis is still facing fallout from last year’s kickbacks case in South Korea. Officials there levied a set of punishments and are weighing "tougher…

Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.

Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

Pharma Asia